Opinion
Video
Challenges in Outpatient Transition For Myelofibrosis Care
Experts discuss obstacles faced while transitioning myelofibrosis patients from inpatient to outpatient care, emphasizing communication, access to medication, and the need for standardized medication reconciliation protocols.
This is a video synopsis/summary of a Peer Exchange involving Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA; James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; Shawn Griffin, PharmD, BCOP; and Robert Mancini, PharmD, BCOP, FHOPA.
In this segment, Mahmoudjafari discusses the challenges of transitioning myelofibrosis patients to outpatient care with Davis. Davis highlights communication as a key hurdle, emphasizing its crucial role in coordinating care between inpatient and outpatient settings. He emphasizes the significance of timely messages from inpatient pharmacists to outpatient providers, detailing the patient’s hospital stay and follow-up plans. Davis identifies communication and access to medications as major obstacles, citing his center’s patient assistance team for addressing the latter. He notes challenges like incomplete discharge summaries, medication lists, and the need for effective medication education. Davis underlines the role of pharmacists in discharge planning, reconciliation, and patient education. He also discusses challenges related to community support and access to care, praising virtual care as a positive development during the pandemic. The segment concludes with Mahmoudjafari addressing the absence of standardized guidelines for medication reconciliation during transitions of care, with Griffin expressing the lack of a clear national guideline and the need for routine integration into electronic medical records.
This summary was AI-generated and reviewed by Pharmacy Times® editorial staff.
